3rd Occupational Health Plan 2016-2020 nano actions review

13/07/2021

Newsflash

health information occupational health prevention regulation

Several actions concerning nanomaterials are listed in the Assessment of the 3rd Occupational Health Plan 2016-2020:

the classification of titanium dioxide as a category 2 carcinogen by inhalation
the initiatives of the network of preventionists in the New Aquitaine region (investigations, meeting and exchange days)
a kit to help identify the nano risk and a webinar produced by the Auvergne Rhône-Alpes regional nano working group (Direccte, Carsat, occupational health services, with the participation of CEA and CFDT)

Nano newsletters produced by the nano group in the Bourgogne Franche-Comté region (volunteer occupational health services, OPPBTP, Direccte)
the study and monitoring of exposure to nanomaterials in connection with the National Health and Environment Plan 4 (PNSE 4), including better use of the R-Nano database

Our information sheets to go further

Jan.

2026

Nanotechnologies and agriculture: a reference framework for responsible practice (AFNOR, online)

On line

Webinar

agriculture

pesticides

standardization

Webconference for analysis laboratories, plant fertilizer manufacturers and distributors, public authorities…
Moderated by David Krupka, nanotechnologies development manager at AFNOR Normalisation and Emilie Langlois-Bertrand, nantechnologies standardization project manager.
In partnership with Armand Masion, CNRS Research Director, and Sandrine Mocoeur, Health, Safety, Environment and Quality Manager at SYNGENTA.
This exchange will also be an opportunity to explore the creation of a national platform to identify standardization needs.
Website: www.afnor.org/evenement/nanotechnologies-agriculture-cadre-pratique-responsable/

Juin

2026

Emerging pathologies and risks (CNMST 2026, Lyon – France)

Lyon

Congress

health

occupational health

prevention

risks

8th Congress of Occupational Medicine and Health (CNMST 2026)
Theme 5: Emerging pathologies and risks, Mr Henri Bastos (ANSES), Pr Lynda Bensefa-Colas (AP-HP), Dr Catherine Nisse (CHU Lille)
Website: www.medecine-sante-travail.com

Juin

2026

Nanomaterials and Health (ANSES, Maisons-Alfort)

Maisons-Alfort

Dialogue Committee